Boss's Boss
2024.12.16 01:36

$XTALPI(02228.HK) Today, JingTai Technology announced a strategic cooperation memorandum with Microsoft China, aiming to leverage cutting-edge technologies such as artificial intelligence (AI), large models, and robotics laboratories to collaborate and actively explore innovative applications of these technologies in the fields of biomedicine and materials science, opening a new chapter in scientific research, education, and innovative applications.

In this cooperation, JingTai Technology will utilize its expertise in the AI for Science R&D platform and the vast multimodal datasets accumulated in its robotics laboratory, combined with Microsoft's large language model (LLM) capabilities, including Azure OpenAI and its high-performance cloud computing platform, to explore vertical large models in the fields of new drug or new material development, and conduct case development in the field of new material design, empowering the R&D of sustainable, environmentally friendly, and energy-efficient new materials. The common goal of both parties is to demonstrate how next-generation computing and automation tools can accelerate innovation in chemistry and materials science, rapidly generate and validate AI-generated molecules that meet necessary property and functional standards, and quickly translate research breakthroughs into competitive products.

JingTai Technology will also explore deploying its proprietary AI-driven molecular generation and molecular dynamics calculation tools on the Microsoft Azure cloud platform to further provide powerful computational support, allowing these precise and efficient intelligent algorithm tools to effectively serve a broader range of enterprises and scientific research, driving scientific innovation on a larger scale, and continuously driving the iterative upgrade of JingTai algorithms.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.